Osimertinib and pterostilbene in EGFR-mutation-positive non-small cell lung cancer (NSCLC)

Monotherapy with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) still leads to incomplete responses in most EGFR-mutation positive non-small cell lung cancer (NSCLC) patients, often due to acquired resistance through activation of parallel compensatory pathways. We have pr...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Int J Biol Sci
Main Authors: Bracht, Jillian Wilhelmina Paulina, Karachaliou, Niki, Berenguer, Jordi, Pedraz-Valdunciel, Carlos, Filipska, Martyna, Codony-Servat, Carles, Codony-Servat, Jordi, Rosell, Rafael
Format: Artigo
Sprog:Inglês
Udgivet: Ivyspring International Publisher 2019
Fag:
Research Paper
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6854375/
https://ncbi.nlm.nih.gov/pubmed/31754333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijbs.32889
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker